US2022396759A1PendingUtilityA1

Recombinant yeast and use thereof

Assignee: ZHANG XUELIPriority: Nov 4, 2016Filed: Jul 12, 2022Published: Dec 15, 2022
Est. expiryNov 4, 2036(~10.3 yrs left)· nominal 20-yr term from priority
C12N 1/18C12R 2001/865C12N 2500/10C12N 2500/38C12N 2500/34C12Y 402/03023C12N 2500/32C12N 9/88C12N 9/1085C12N 15/81C07K 2319/00C12Y 205/0101C12P 5/002C12N 1/185C12P 5/007C12N 2500/05
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided is a recombinant yeast expressing germacrene A synthetase or a fusion protein thereof, wherein the fusion protein is germacrene A synthetase and farnesyl pyrophosphate synthase. The recombinant yeast improves the yield of germacrene A, and is suitable for the industrialized production of β-elemene and/or germacrene A.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A recombinant strain, which is a yeast comprising or expressing germacrene A synthetase or a fusion protein of germacrene A synthetase m vivo;
 the fusion protein of germacrene A synthetase comprises the germacrene A synthetase and farnesyl pyrophosphate synthase.

Join the waitlist — get patent alerts

Track US2022396759A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.